Orthofix International | OFIX - Ebitda


Orthofix International reported $27.88M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 17.07M 2.79M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
EDAP TMS EUR -4.92M 843K Sep/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
J&J USD 7.19B 2.32B Dec/2025
Medtronic USD 2.81B 119M Mar/2026
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 27.88M 2.77M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Smith & Nephew USD 796M 139M Dec/2025
STAAR Surgical USD -159K 34.78M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Veracyte USD 42.8M 488K Mar/2026
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025